Gilead Sciences, Inc. (GILD)

We're flying high boys!

Gilead is a pioneer in the development of HIV & other immune related diseases and with new science coming on stream it is a likely take-over candidate by a major pharma firm.

I'm not much into purchasing the large and mega caps because a double is most likely the top of the run even for a growth machine like this one, and I'm also addicted to the longshots, but for the simple man just looking to turn a profit. Here she is. Buy $30 to $35 it most likely won't add very many points in your caps account as it slowly rises in dollars to the $50 or $60 range because caps does not register points from dollar gains but more so from daily S&P gains or losses compared to the stock.Bought the stock myself Feb 2005 for $17 and held it until may 2008 and it grew like grass. Even as big as it is,still growing like a tree.Beat est 6 out of the last 8 calls and estimates were increased 10/24/09. 2nd quarter 2009 rang in above 38% compared to last years 2nd quarter. P/E 17.00 Forward P/E 14.00 ,PEG 1.0 ,5 year sales growth 43% ,Gross Margins 77.00% , Net Profit Margins 37.00% ,ROE 47.00 Dept/Equity Ratio very low 0, Free cash flow superb. Company already upped full year 2009 guidance on both sales and revenue. I fully invested else where early part of this year and own no shares of this monster anymore,but for those still looking. You may want to give this one a hard look and catch it on the dip.

1/166 in Biotechnolgy -(77.8 @ A/A+)

I like the statistics about this company, a good margin, effective management numbers good roi and roic, i dont see a lot not to like, except that it operates from within the veil of the great OZ (or one of them) the FDA) haha.

Highest quality growth. The revenue chart is a thing of beauty. Very high ROE.

77

Pharmaceutical stock GILD, having acquired a few other companies recently, will continue to grow earnings as surely as viruses will continue to need treaments.

Great potential

Strong growth in this sector

Picking stocks based on holdings of a top mutual fund in my 401k.

New approval

Gilead is the fastest growing of the "blue chip biotechs". And biotechnology is the nr.1 boom industry of the 21st century.

This is my bio-tech pick.

This stock unfortunately gets punished every time it reports strong profits, the recovers......

works with AIDS drugs and developement study

As long as GILD's Atripla continues to be the lead choice of a single dose / single pill HIV treatment, it will gain market share as doctors put patients on this drug.

Recent study showing that the company's anti-HIV drugs can be used in Africa without constant lab test monitoring of patients should boost significantly its opportunities in developing markets.

Negatives can be competitors coming up with their own one pill / once-per-day HIV drugs or alternative therapies appearing. Those are still at least few years away.

great stock

Create treatement for aids....Cant go wrong, who doesnt love sex, especially women!